文献速递疼痛医学区域麻醉与超声

局部交感神经切除术促进抗炎反应并缓解紫杉醇诱导的小鼠机械性和冷异常性疼痛

Local Sympathectomy Promotes Anti-inflammatory Responses and Relief of Paclitaxel-induced Mechanical and Cold Allodynia in Mice.
PubMed 文献 · Anesthesiology · 2020-01-01

该研究在小鼠紫杉醇化疗模型中实施局部交感神经切除术,发现其可快速缓解机械性异常性疼痛并预防冷异常性疼痛,机制涉及背根神经节巨噬细胞标志物和抗炎细胞因子如转化生长因子-β的转录增加,且该效应依赖于单核/巨噬细胞和转化生长因子-β信号。

要点

  • 局部交感神经切除术可快速缓解紫杉醇诱导的机械性异常性疼痛。
  • 局部交感神经切除术可预防紫杉醇诱导的冷异常性疼痛。
  • 抗炎机制涉及巨噬细胞和转化生长因子-β信号通路。

核心结论

  • 局部交感神经控制背根神经节免疫反应进展和紫杉醇后疼痛行为,提示临床局部交感神经阻滞可能有效治疗化疗诱导的神经病理性疼痛。

研究设计与样本

  • 在小鼠腹腔注射紫杉醇后行局部交感神经切除术(切断同侧进入L3和L4背根神经节附近脊神经的灰交通支),评估疼痛行为、神经免疫和电生理反应。

主要发现

  • 局部显微交感神经切除术使雄性小鼠第5天机械性异常性疼痛快速恢复(均值±标准差:交感神经切除术组vs假手术组,1.07±0.34 g vs 0.51±0.17 g,n=5,P=0.030),雌性小鼠类似(1.08±0.28 g vs 0.62±0.16 g,n=5,P=0.036)。
  • 局部显微交感神经切除术预防雄性和雌性小鼠紫杉醇后冷异常性疼痛的发展。
  • 局部显微交感神经切除术诱导背根神经节巨噬细胞标志物和抗炎细胞因子如转化生长因子-β的转录增加。
  • 耗竭单核/巨噬细胞和阻断转化生长因子-β信号逆转局部显微交感神经切除术对机械性异常性疼痛的缓解。
  • 外源性转化生长因子-β足以缓解紫杉醇后机械性异常性疼痛(雄性小鼠3小时:转化生长因子-β 100 ng/site vs 载体,1.21±0.34 g vs 0.53±0.14 g,n=5,P=0.001),且转化生长因子-β信号调节背根神经节神经元活动。

临床怎么用

  • 临床已使用的局部交感神经阻滞策略可能为化疗诱导神经病理性疼痛患者提供有效治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patients undergoing cancer treatment often experience chemotherapy-induced neuropathic pain at their extremities, for which there is no U.S. Food and Drug Administration-approved drug. The authors hypothesized that local sympathetic blockade, which is used in the clinic to treat various pain conditions, can also be effective to treat chemotherapy-induced neuropathic pain. METHODS: A local sympathectomy (i.e., cutting the ipsilateral gray rami entering the spinal nerves near the L3 and L4 dorsal root ganglia) was performed in mice receiving intraperitoneal injections every other day of the chemotherapeutic drug paclitaxel. Sympathectomy effects were then assessed in chemotherapy-induced pain-like behaviors (i.e., mechanical and cold allodynia) and neuroimmune and electrophysiologic responses. RESULTS: Local microsympathectomy produced a fast recovery from mechanical allodynia (mean ± SD: sympathectomy vs. sham at day 5, 1.07 ± 0.34 g vs. 0.51 ± 0.17g, n = 5, P = 0.030 in male mice, and 1.08 ± 0.28 g vs. 0.62 ± 0.16 g, n = 5, P = 0.036 in female mice) and prevented the development of cold allodynia in both male and female mice after paclitaxel. Mechanistically, microsympathectomy induced transcriptional increases in dorsal root ganglia of macrophage markers and anti-inflammatory cytokines, such as the transforming growth factor-β. Accordingly, depletion of monocytes/macrophages and blockade of transforming growth factor-β signaling reversed the relief of mechanical allodynia by microsympathectomy. In particular, exogenous transforming growth factor-β was sufficient to relieve mechanical allodynia after paclitaxel (transforming growth factor-β 100 ng/site vs. vehicle at 3 h, 1.21 ± 0.34g vs. 0.53 ± 0.14 g, n = 5, P = 0.001 in male mice), and transforming growth factor-β signaling regulated neuronal activity in dorsal root ganglia. CONCLUSIONS: Local sympathetic nerves control the progression of immune responses in dorsal root ganglia and pain-like behaviors in mice after paclitaxel, raising the possibility that clinical strategies already in use for local sympathetic blockade may also offer an effective treatment for patients experiencing chemotherapy-induced neuropathic pain.

来源:Anesthesiology,查看原文。版权归原作者所有。

引用

  1. Tonello R, Xie W, Lee SH, et al. Local Sympathectomy Promotes Anti-inflammatory Responses and Relief of Paclitaxel-induced Mechanical and Cold Allodynia in Mice. Anesthesiology. 2020. PMID: 32404819. doi:10.1097/ALN.0000000000003241

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。